Over the years, DUPHAT has served as a major platform for diverse stakeholders in the pharmaceutical industry to launch new products, learn about new technologies and developments, acquire new scientific knowledge and network with their peers in the sector. The record of participation in the event reflects Dubai’s emergence as a major global hub for both the healthcare and pharmaceutical sectors.

Moreover, DUPHAT 2024 unfolds as the most expansive edition of the event to date with over 1,300 exhibiting companies participating. Some of the largest and most influential companies in the industry, including international powerhouses Pfizer, AstraZeneca, GSK, Gilead, Julphar, Axios, Haleon, AbbVie and Lilly, are in attendance.

Innovative hub

DUPHAT 2024 introduces an exclusive platform, featuring the Pharma Business Hub, CEO Meeting, and Tech Hub, bringing together key decision-makers, potential buyers, suppliers, and manufacturers in the pharmaceutical sector. This innovative hub enables pre-arranged one-to-one B2B meetings with top exhibitors, fostering collaboration and exploration of business opportunities. Furthermore, The event will support stakeholders and drive the exploration of new avenues for growth in the dynamic pharmaceutical industry.

Also Read: DUPHAT 2024 is set to kick off tomorrow

INDEX Conferences and Exhibitions, a member of INDEX Holding, organize DUPHAT annually. It receives support from Dubai Health Authority, American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia, and the European Society of Oncology Pharmacy.